Benchmark reit the purchase rating on the stock of Silicon Laboratories (slabs), maintains PT at $ 160
On May 21, Benchmark reiterated its purchase rating on the actions of Silicon Laboratories Inc. (Nasdaq: Slab), keeping the price target at $ 160.
Cody Acree by Benchmark Co. kept its note on the slab after having evaluated the position of the company market and future growth prospects following the results of the first quarter. The turnover of $ 178 million in the company in the first quarter of 2025 was 7% higher than the T2 2024 and 67% higher from one year.
A technician looking at a circuit card printed with analog semiconductor products.
Acree highlighted the company’s high foot in the semiconductor industry, driven by its innovative product offers and strategic initiatives to extend its market share. The company began production of its first device in its new generation serial 3 platform on 22 NM process technology. This series will be an upgrade of the 2 series with a higher calculation power and capabilities. The company also advances the production of its MG26 family of wireless SOC, which allows developers to design material applications to the test of future.
The analyst remains optimistic about the slab because he considers that his strong sources of income are a key growth factor. Silicon Laboratories’ domicile and life activities almost doubled one year in the first quarter, publishing a turnover of around $ 82 million. Industrial and commercial activity has also experienced two -figure growth a year ago, displaying $ 96 million in income.
Silicon Laboratories Inc. (NASDAQ: SLAB) is a company of without infer semiconductors which engages in a safe and intelligent wireless technology for a connected world. Its integrated hardware and software systems allow customers to create advanced, commercial, domestic and life applications.
While we recognize the potential of the growth slab, our conviction lies in the conviction that certain AI actions are more promising to offer higher yields and have a limited risk of decline. If you are looking for a more promising stock of AI than the slab and which has 100x upward potential, consult our report on this subject Stock ai the cheapest.
Then read: 30 best actions to buy now according to billionaires and 15 small capitalization health care actions buy.
Disclosure. None.
